The European Medicines Agency Clinical Data Website Enables Insights I | OAJCT
Rings in Clinical Trials and Drugs: Present and Future | Journal of Medicinal Chemistry
New Draft EMA-Guideline On Clinical Development Of Fixed Combination Medicines | The National Law Review
EMA Drafts New Clinical Development Guideline for Fixed Dose Combination Drugs | RAPS
OVERVIEW OF COMMENTS RECEIVED ON DRAFT GUIDELINE ON FIXED COMBINATIONS – REV 1
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis - The Lancet
PDF) Fixed-Dose Combination in Diabetes Management
Guideline on clinical development of fixed combination medicinal products - The IMPT
Challenges and opportunities to include patient‐centric product design in industrial medicines development to improve therapeutic goals - Timpe - 2020 - British Journal of Clinical Pharmacology - Wiley Online Library
Guideline on clinical development of fixed combination_ public consultation
Leveraging multi-way interactions for systematic prediction of pre-clinical drug combination effects | Nature Communications
The European Medicines Agency Clinical Data Website Enables Insights I | OAJCT
Guideline on Fixed Combinations
Latest hypertension research to inform clinical practice in Asia | Hypertension Research
Guideline on clinical development of fixed combination
Network-based prediction of drug combinations | Nature Communications
FDC GDL _overview of comments
EMA Adopts Updated Guideline on Fixed Dose Combination Drugs | RAPS
A Review on Drug Combination Strategy for Pharma Life Cycle Management
Reporting guideline for the early-stage clinical evaluation of decision support systems driven by artificial intelligence: DECIDE-AI | Nature Medicine
Pharmaceutics | Free Full-Text | Patient Centric Pharmaceutical Drug Product Design—The Impact on Medication Adherence | HTML
Use of fixed-dose combination antihypertensives in Germany between 2016 and 2020: an example of guideline inertia | SpringerLink
Frontiers | Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales
Regulatory guidelines and preclinical tools to study the biodistribution of RNA therapeutics - ScienceDirect
